Quantum Biopharma Ltd (QNTM) Stock Price, Quote & News

Company Profile

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company's lead compound is Lucid-MS, a patented new chemical enti...

Industry: Biotechnology

Sector: Healthcare

Phone: 833 571 1811

Website: www.quantumbiopharma.com

Address:

1 Adelaide Street East, Suite 801, Toronto, Canada

Rambler1111 May. 11 at 7:21 PM

$QNTM It’s been very QUIET for a company who announced they hired a PR company a few weeks ago. I really hope they unleash some big news soon and justify the reason they were hired .

0 · Reply

toxicdogie May. 11 at 6:58 PM

$QNTM $10++ sooner than most think Won’t take much and so many positive catalyst any minute now

0 · Reply

anton3 May. 11 at 6:37 PM

$QNTM Quantum + pharma? interesting

0 · Reply

Rambler1111 May. 11 at 6:36 PM

$QNTM

0 · Reply

toxicdogie May. 11 at 1:26 PM

$QNTM Be ready, awesome week ahead

0 · Reply

xHiddenGems May. 10 at 8:15 PM

AMS 💎 If you ain't bullish enough here I don't know what to say! AMS trending #3 on Stocktwits, bullish as it gets. Life changing money will be made here next week, don't be left behind on this opportunity! $ACHR $QCOM $QNTM $ILLR ..ww8

0 · Reply

Vapor83 May. 9 at 1:59 PM

$QNTM guessing we get trial news this week and a 100% jump

0 · Reply

FickleFin May. 8 at 2:40 PM

$QNTM $GNS its called... leverage. Paid by retail investors. They pump. They pocket. This company is a lie. 2nd picture is 3 different aliases under 1 person stating the same narrative but cross tagging different tickers. 🚩🚩🚩🚩

1 · Reply

ZacksResearch May. 7 at 7:02 PM

$QNTM just doubled its liquidity — and the biotech pipeline is still moving full speed 🚀 💰 Cash, cash equivalents + digital assets jumped to $9.8M in Q1, up from $4.1M at year-end 📉 Operating cash burn dropped 60% YoY after Phase 1 trial completion 🧬 Lucid-MS IND officially submitted to the FDA, with Phase 2 plans advancing alongside Allucent Meanwhile, management says current liquidity could fund operations through approximately July 2027. See what Wall Street expects next 👉 https://www.zacks.com/stock/research/QNTM/price-target-stock-forecast?cid=sm-stocktwits-0-price_target-oc-38021&ADID=SYND_STOCKTWITS_TWEET_0_PRICETARGET_OC_38021

1 · Reply

toxicdogie May. 7 at 12:35 PM

$QNTM same update soon which will result to $ATRA s gain Enjoy the cheapies-won’t last FDA soon

1 · Reply